CCM
Consonance Capital Management Portfolio holdings
AUM
$7.28M
This Quarter Return
+15.6%
1 Year Return
-42.86%
3 Year Return
+319.33%
5 Year Return
+899.35%
10 Year Return
–
AUM
$707M
AUM Growth
+$707M
(+6.9%)
Cap. Flow
-$33.7M
Cap. Flow
% of AUM
-4.77%
Top 10 Holdings %
Top 10 Hldgs %
81.61%
Holding
26
New
4
Increased
7
Reduced
9
Closed
4
Top Buys
| 1 |
United Therapeutics
UTHR
|
$44.3M |
| 2 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$40.3M |
| 3 |
Penumbra
PEN
|
$38.3M |
| 4 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$27.4M |
| 5 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
$24.2M |
Top Sells
| 1 |
NUVA
NuVasive, Inc.
NUVA
|
$50.2M |
| 2 |
MACK
Merrimack Pharmaceuticals, Inc.
MACK
|
$49.2M |
| 3 |
AbbVie
ABBV
|
$47.6M |
| 4 |
AGN
Allergan plc
AGN
|
$25.5M |
| 5 |
Pacific Biosciences
PACB
|
$23.9M |
Sector Composition
| 1 | Healthcare | 88.78% |